stallimycin

This page covers all stallimycin drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting GTPase HRas, DNA topoisomerase 1, Estrogen receptor.

Targets

GTPase HRas, DNA topoisomerase 1, Estrogen receptor

Phase 2 pipeline (1)

• Distamycin 3 · Other
  Distamycin 3 works by binding to the estrogen receptor, disrupting its interaction with estrogen and potentially inhibiting its activity.

Patent intelligence

• stallimycin patent landscape — aggregated cliff calendar, attackable patents, originator estates